GEXVal Featured by Australian Media Outlets

GEXVal Inc.
October 13, 2022

GEXVal has announced that it has met Nick Champion, a member of the South Australian parliament (Minister of Trade and Investment, Minister of Housing and Urban Development, and Minister of Planning), reported on the start of Phase 1 clinical trials of GXV-001, and exchanged opinions on strengthening collaboration in the future. An outline of the meeting was featured on the official website of South Australian government and on the Twitter account of Nick Champion, who is a minister in the South Australian government.

Links to each article:
Website of the South Australian government
https://dti.sa.gov.au/articles/south-australia-lures-leading-biotech-company-gexval-clinical-trials

https://www.linkedin.com/posts/depttradeinvestment_south-australia-lures-leading-biotech-company-activity-6986165655154688000-D9c8?utm_source=share&utm_medium=member_desktop

Nick Champion’s Twitter
https://twitter.com/NickChampionMP/status/1580298467850612737

Indaily
https://indaily.com.au/news/2022/10/13/japanese-biotech-company-to-undertake-clinical-trials-in-sa/

GEXVal strives for research & development toward devising promising drugs for patients and their family that desperate for better treatment as soon as possible.

Note: The development scale described in each article is not true, and GEXVal did not disclose any certain amounts of funds.

 

For future information, please contact us: info@gexval.com